Abstract:Cone-Rod Homeobox, encoded by , is a transcription factor (TF) essential for the terminal differentiation and maintenance of mammalian photoreceptors. Structurally, CRX comprises an ordered DNA-binding homeodomain and an intrinsically disordered transcriptional effector domain. Although a handful of human variants in have been shown to cause several different degenerative retinopathies with varying cone and rod predominance, as with most human disease genes the vast majority of observed genetic variants are uncharacterized variants of uncertain significance (VUS). We performed a deep mutational scan (DMS) of nearly all possible single amino acid substitution variants in CRX, using an engineered cell-based transcriptional reporter assay. We measured the ability of each CRX missense variant to transactivate a synthetic fluorescent reporter construct in a pooled fluorescence-activated cell sorting assay and compared the activation strength of each variant to that of wild-type CRX to compute an activity score, identifying thousands of variants with altered transcriptional activity. We calculated a statistical confidence for each activity score derived from multiple independent measurements of each variant marked by unique sequence barcodes, curating a high-confidence list of nearly 2,000 variants with significantly altered transcriptional activity compared to wild-type CRX. We evaluated the performance of the DMS assay as a clinical variant classification tool using gold-standard classified human variants from ClinVar, and determined that activity scores could be used to identify pathogenic variants with high specificity. That this performance could be achieved using a synthetic reporter assay in a foreign cell type, even for a highly cell type-specific TF like CRX, suggests that this approach shows promise for DMS of other TFs that function in cell types that are not easily accessible. Per-position average activity scores closely aligned to a predicted structure of the ordered homeodomain and demonstrated position-specific residue requirements. The intrinsically disordered transcriptional effector domain, by contrast, displayed a qualitatively different pattern of substitution effects, following compositional constraints without specific residue position requirements in the peptide chain. The observed compositional constraints of the effector domain were consistent with the acidic exposure model of transcriptional activation. Together, the results of the DMS identify molecular features of the CRX effector domain and demonstrate clinical utility for variant classification.

Scalable Dual-Fluorescence Assay for Functional Interpretation of HNF-4α Missense Variants

Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects

Application of Capillary Electrophoresis in Detecting Mutation of Hmlh1 Gene in Colorectal Cancer

Functional Assessment of Protein Variants in Structured Domains by Fluorescence Cross-Correlation Spectroscopy

An Automated Fluorescent Single Strand Conformation Polymorphism Technique for High Throughput Mutation Screening.

Saturation mutagenesis-reinforced functional assays for disease-related genes

Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4

A High Resolution Genome-Wide Scan of HNF4α Recognition Sites Infers a Regulatory Gene Network in Colon Cancer

Achieving single nucleotide sensitivity in direct hybridization genome imaging

Functional Imaging-Guided Cell Selection for Evolving Genetically Encoded Fluorescent Indicators.

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Functional evaluation of rare variants in complement factor I using a minigene assay

Functional characterization of all missense variants and comparison to in silico models of pathogenicity

CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency

A High-Throughput in Vivo Selection Method for Luciferase Variants

RNA variant assessment using transactivation and transdifferentiation

Mutational scanning of classifies clinical variants and reveals biochemical properties of the transcriptional effector domain

A sensitive fluorescence anisotropy method for point mutation detection by using core-shell fluorescent nanoparticles and high-fidelity DNA ligase.

Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches

Abstract 3536: Paracell: A high throughput, deep learning-based pipeline for single-cell phenotypic profiling

P011 Advances in HLA Clinical Relevant Exon Novelty Detection from over 21,000 Donor Recruitment Samples